ACDF + PCF for Degenerative Disc Disease

(SECOND Trial)

SU
MJ
Overseen ByMatt Jenkins
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Providence Medical Technology, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The objective of this clinical trial is to evaluate the treatment of patients with two-level cervical degenerative disease using a combination of Anterior Cervical Discectomy and Fusion (ACDF) and Posterior Cervical Fusion (PCF) procedures.

The primary outcome measure is the rate of fusion success in the investigational treatment arm (ACDF + PCF) compared with the control arm (ACDF alone) at the 12-month follow-up visit.

Researchers will compare the investigational treatment arm (ACDF + PCF) to the control arm (ACDF alone) to assess superiority in terms of fusion success rate.

Who Is on the Research Team?

MJ

Matt Jenkins

Principal Investigator

Providence Medical Technology, Inc.

Are You a Good Fit for This Trial?

Inclusion Criteria

Written informed consent provided by subject
I am at least 18 years old and fully grown.
My imaging shows spine problems that match my main symptoms.
See 5 more

Exclusion Criteria

Anticipated relocation >50 miles interfering with follow-up completion
I have spondylolisthesis that is grade 3 or higher.
I was born with bone or spinal cord problems that affect my spine's stability.
See 24 more

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Circumferential Cervical Fusion (CCF)Experimental Treatment1 Intervention
Group II: Anterior Cervical Discectomy and Fusion (ACDF)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Providence Medical Technology, Inc.

Lead Sponsor

Trials
3
Recruited
240+